Home > Dermatology > SPIN 2022 > Psoriasis: The Beat Goes On > Topical therapy in psoriasis: an important partner in combination therapy

Topical therapy in psoriasis: an important partner in combination therapy

Presented By
Prof. Peter van de Kerkhof, Radboud University Medical Centre, the Netherlands
Conference
SPIN 2022
Doi
https://doi.org/10.55788/7c543535
The therapeutic efficacy of a systemic agent can not only be enhanced by dose escalation but also by combination with topical treatment. Choosing the right vehicle is especially important in scalp psoriasis. In many patients, psoriasis shows a relapsing course with remissions and exacerbations and is sometimes refractory to treatment. In case of systemic treatment, escalating dosage, shortening injection intervals, or switching therapy is not the only way to enhance therapeutic efficacy. As Prof. Peter van de Kerkhof (Radboud University Medical Centre, the Netherlands) pointed out in his lecture, adding topical therapy to systemic agents might be a smart way to improve efficacy without safety concerns [1]. Today, combination therapies have shown improved efficacy compared with monotherapy with systemic agents [2]. Until today, topical corticosteroids play a key role in the treatment of psoriasis, especially for localised disease, due to their anti-inflamma...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on